Cordycepin (CA) can activate the Nrf2/HO-1/NF-κB pathway for its anti-hepatocarcinoma effect in N-nitrosodiethylamine (NDEA)-induced mouse hepatocellular carcinomas (Zeng et al., 2017). Here, NFKB1 is linked to hepatocellular carcinoma.